Study guide
7.5 Recognizing Complications, Infection Signs, & When to Seek Care
NAWCCB WCC Wound Care Certified Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the NAWCCB WCC Exam How to Use This Study Guide
2 Assessment: Skin & Tissue Foundations
1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric
3 Assessment: Diagnostic Tools & Risk Assessment
2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
4 Treatment: Dressing Selection & Debridement Modalities
3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical
5 Treatment: Advanced Therapies & Specialized Management
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT
6 Reevaluation & Wound Healing Trajectory
5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence
7 Risk Reduction & Prevention Strategies
6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment
8 Patient & Caregiver Education
7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media
9 Administration & Program Management
8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization
10 Legal, Ethical, & Scope of Practice
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection
7.5 Recognizing Complications, Infection Signs, & When to Seek Care
Key Takeaways Explain This Topic AI
Localized wound infection (superficial) is identified using the NERDS criteria (Non-healing, Exudate increase, Red/bleeding friable tissue, Debris/slough, Smell/malodor), requiring topical antimicrobial therapy.
Deep or spreading infection is recognized via the STONEE criteria (Size increasing, Temperature elevated, Osteomyelitis/probe to bone, New areas of breakdown, Erythema >2 cm, Exudate/Edema), requiring systemic antibiotics.
Systemic infection red flags include body temperature >38.0°C (100.4°F) or <36.0°C (96.8°F), heart rate >90 bpm, respiratory rate >20/min, WBC >12,000/mcL, or unexplained blood glucose >200 mg/dL in diabetic patients.
Spreading erythema extending >2 cm beyond the wound border within 24 hours signifies active cellulitis requiring immediate medical evaluation.
Emergency red flags including subcutaneous crepitus (gas gangrene), rapid tissue necrosis, severe ischemic pain, or SIRS/sepsis criteria mandate immediate transfer to an emergency department.
Last updated: August 2026
Recognizing Complications, Infection Signs, & When to Seek Care
Wound infection represents a continuum that ranges from superficial bacterial colonization to deep soft-tissue invasion, osteomyelitis, and life-threatening systemic sepsis. Because patients with diabetes, peripheral arterial disease, or immunosuppression often exhibit blunted inflammatory responses, classic infection signs may be subtle or absent. Clinicians must equip patients, family caregivers, and home health staff with standardized diagnostic frameworks—specifically the NERDS and STONEE criteria—to identify local versus deep infection early, establishing clear protocols for immediate emergency medical escalation.
The Wound Infection Continuum
Microbial burden on the wound surface progresses through five distinct stages:
Contamination: Non-replicating bacteria present on the wound surface; no host tissue reaction.
Colonization: Replicating bacteria present without host tissue damage or clinical infection.
Local Infection (Covert / Overt): Microorganisms proliferate within the superficial wound bed, triggering a localized inflammatory response, biofilm formation, and stalled healing.
Spreading Infection: Microorganisms invade deep soft tissues beyond the wound border, causing cellulitis, lymphangitis, or deep abscess.
Systemic Infection (Sepsis): Pathogens or toxic bacterial products enter the bloodstream, triggering Systemic Inflammatory Response Syndrome (SIRS), multi-organ failure, and septic shock.
Diagnostic Frameworks: NERDS vs. STONEE
To guide targeted therapy, clinical infection signs are categorized into superficial/local infection ( NERDS ) versus deep/spreading infection ( STONEE ).
NERDS Criteria (Superficial / Local Infection - High Biofilm Burden)
When 3 or more of the following criteria are present, localized superficial infection is diagnosed:
N on-healing wound: Progress has stalled for > 2 weeks despite appropriate off-loading or dressing management.
E xudate increase: Sudden escalation in drainage volume or change to purulent consistency.
R ed and bleeding friable tissue: Granulation tissue appears dark red, dull, exuberant, and bleeds easily upon gentle contact.
D ebris / Slough: Rapid accumulation of yellow/gray necrotic slough or stringy exudate within the wound bed.
S mell / Malodor: New onset of foul odor upon dressing removal.
Clinical Management: Treated primarily with topical antimicrobial dressings (e.g., medical-grade silver, cadexomer iodine, honey) and aggressive biofilm-disrupting wound bed debridement. Systemic antibiotics are generally not indicated for localized NERDS infection.
STONEE Criteria (Deep / Spreading Tissue Infection)
When 3 or more of the following criteria are present, deep invasive infection is diagnosed:
S ize increasing: Wound dimensions (length, width, or depth) enlarge despite treatment.
T emperature elevated: Periwound skin temperature increases by >= 1.1 to 2.2°C (2 to 4°F) compared to surrounding normal skin.
O steomyelitis / Probe-to-bone: Metallic probe easily contacts hard, gritty bone at the wound base, or bone is visually exposed.
N ew areas of breakdown: Satellite ulcers, tissue sinus tracts, or bullae form in periwound skin.
E rythema extending > 2 cm beyond the wound border.
E xudate / Edema / Induration: Spreading tissue edema and firm induration extending into surrounding structures.
Clinical Management: Mandates systemic oral or intravenous broad-spectrum antibiotics , urgent imaging (x-rays, MRI), surgical consult for deep space debridement, and wound cultures.
Systemic Infection Red Flags & SIRS Criteria
Systemic infection represents a medical emergency. Clinicians, patients, and caregivers must monitor for systemic toxicity indicators:
Systemic Inflammatory Response Syndrome (SIRS) Parameters
Systemic sepsis is defined by the presence of 2 or more of the following clinical criteria in the setting of a wound infection:
Core Body Temperature: > 38.0°C (100.4°F) OR < 36.0°C (96.8°F) (hypothermia indicates severe septic shock).
Heart Rate: > 90 beats per minute (tachycardia).
Respiratory Rate: > 20 breaths per minute (tachypnea) or PaCO2 < 32 mmHg.
Leukocyte Count (WBC): > 12,000/µL , < 4,000/µL, or > 10% immature band forms.
Unexplained Hyperglycemia in Diabetes
In diabetic patients, a sudden, unexplained elevation in blood glucose ( > 200 mg/dL or > 11.1 mmol/L) despite compliance with insulin/medication regimens is frequently the earliest indicator of deep tissue infection, occurring 24 to 48 hours before clinical fever or spreading redness appears due to stress-induced cortisol and inflammatory cytokine release.
Emergency Red Flags & Immediate Escalation Protocol
Patients and caregivers must receive a written card detailing explicit "Red Flag" symptoms that require immediate transfer to an Emergency Department (ED):
Rapidly Spreading Cellulitis: Periwound redness expanding > 2 cm within a 24-hour period, or red streaks ascending the limb (lymphangitis).
Subcutaneous Crepitus: A crackling, bubbling sensation felt under the skin upon gentle palpation, signifying subcutaneous gas produced by anaerobic gas-forming organisms (e.g., Clostridium perfringens , polymicrobial necrotizing fasciitis).
Tissue Necrosis & Gangrene: Blackening of skin (eschar formation), purple discoloration, fluid-filled bullae, or sudden loss of sensation in a previously painful wound.
Severe Unrelieved Ischemic Pain: Excruciating, sudden lower extremity pain unalleviated by elevation or analgesics, signaling acute arterial thrombosis or compartment syndrome.
Systemic Collapse: Confusion, severe lethargy, rigors/chills, diaphoresis, or systemic hypotension (systolic BP < 90 mmHg).
Infection Level Diagnostic Criteria Framework Key Clinical Manifestations Primary Therapeutic Intervention
Superficial / Local Infection NERDS (>=3 criteria present) Non-healing, Exudate inc, Red friable tissue, Debris, Smell Topical antimicrobial dressings (Silver, Iodine) + Debridement
Deep / Spreading Infection STONEE (>=3 criteria present) Size inc, Temp inc, Probe to bone, New breakdown, Erythema >2cm Systemic oral/IV antibiotics + Imaging (MRI) + Surgical consult
Systemic Infection / Sepsis SIRS (>=2 criteria present) Temp >38°C / <36°C, HR >90, RR >20, WBC >12,000, Glucose >200 Immediate Emergency Department transfer + IV fluids + IV antibiotics
Necrotizing Soft Tissue Emergency Red Flags Subcutaneous crepitus, rapid black necrosis, bullae, severe pain Emergency surgical debridement + Broad IV coverage + Hyperbaric O2